Bryn Mawr Trust CO Dynavax Technologies Corp Transaction History
Bryn Mawr Trust CO
- $5.51 Billion
- Q2 2025
A detailed history of Bryn Mawr Trust CO transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Bryn Mawr Trust CO holds 6,000 shares of DVAX stock, worth $61,980. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,000
Previous 8,000
25.0%
Holding current value
$61,980
Previous $103,000
42.72%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding DVAX
# of Institutions
309Shares Held
128MCall Options Held
493KPut Options Held
274K-
Black Rock Inc. New York, NY21.9MShares$226 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT17.8MShares$184 Million8.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.7MShares$89.9 Million0.0% of portfolio
-
State Street Corp Boston, MA6.79MShares$70.1 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA5.75MShares$59.4 Million4.84% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.31B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...